{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:39:59Z","timestamp":1777343999384,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Science and Technology, Government of India under FIST program"},{"name":"University Grants Commission Special Assistance Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Octanoic acid is a medium-chained saturated fatty acid found abundantly in the ketogenic dietary supplements containing medium chained triglycerides (MCT) along with decanoic acid. The MCT ketogenic diet is commonly consumed for weight loss but has also showcased neuroprotective potential against neurodegenerative disorders. However, recent clinical findings have reported a critical disadvantage with the long-term consumption of ketogenic diet i.e. bone loss. The following study was employed to investigate whether the two major components of MCT diet also possess bone loss potential as observed with classical ketogenic diet. Swiss albino mice aged between 10 and 12\u00a0weeks, were divided into 3 treatment groups that were administered with oral suspensions of octanoic acid, decanoic acid and a combination of both for 4\u00a0weeks. Bone specific markers, microarchitectural parameters, using micro computed tomography, and biomechanical strength were analyzed. Remarkably deleterious alterations in the trabecular bone microarchitecture, and on bone markers were observed in the octanoic acid treated groups. Our results suggest significant negative effects on bone health by octanoic acid. These findings require further investigation and validation in order to provide significant clinically relevant data to possibly modify dietary composition of the MCT ketogenic diet.<\/jats:p>","DOI":"10.1038\/s41598-021-86468-9","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T11:03:37Z","timestamp":1616756617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Octanoic acid a major component of widely consumed medium-chain triglyceride ketogenic diet is detrimental to bone"],"prefix":"10.1038","volume":"11","author":[{"given":"Shreshta","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"86468_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.idairyj.2006.06.015","volume":"16","author":"B Marten","year":"2006","unstructured":"Marten, B., Pfeuffer, M. & Schrezenmeir, J. Medium-chain triglycerides. Int. Dairy J. 16, 1374\u20131382 (2006).","journal-title":"Int. Dairy J."},{"key":"86468_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/ane.12592","volume":"135","author":"DA Lambrechts","year":"2017","unstructured":"Lambrechts, D. A. et al. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol. Scand. 135, 231\u2013239. https:\/\/doi.org\/10.1111\/ane.12592 (2017).","journal-title":"Acta Neurol. Scand."},{"key":"86468_CR3","doi-asserted-by":"publisher","first-page":"CD001903","DOI":"10.1002\/14651858.CD001903.pub4","volume":"11","author":"KJ Martin-McGill","year":"2018","unstructured":"Martin-McGill, K. J., Jackson, C. F., Bresnahan, R., Levy, R. G. & Cooper, P. N. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst. Rev. 11, CD001903. https:\/\/doi.org\/10.1002\/14651858.CD001903.pub4 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"86468_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yebeh.2015.07.023","volume":"51","author":"DA Lambrechts","year":"2015","unstructured":"Lambrechts, D. A. et al. The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: a prospective study with 2-year follow-up. Epilepsy Behav. 51, 261\u2013266 (2015).","journal-title":"Epilepsy Behav."},{"key":"86468_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-019-0471-4","author":"T Prasoppokakorn","year":"2019","unstructured":"Prasoppokakorn, T., Jirasakuldej, S. & Lakananurak, N. Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review. Eur. J. Clin. Nutr. https:\/\/doi.org\/10.1038\/s41430-019-0471-4 (2019).","journal-title":"Eur. J. Clin. Nutr."},{"key":"86468_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","volume":"50","author":"EG Neal","year":"2009","unstructured":"Neal, E. G. et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50, 1109\u20131117. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01870.x (2009).","journal-title":"Epilepsia"},{"key":"86468_CR7","doi-asserted-by":"crossref","unstructured":"Azzam, R. & Azar, N. J. Marked seizure reduction after MCT supplementation. Case Reports in Neurological Medicine 2013 (2013).","DOI":"10.1155\/2013\/809151"},{"key":"86468_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2319-4170.107154","volume":"36","author":"YM Liu","year":"2013","unstructured":"Liu, Y. M. & Wang, H. S. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. 36, 9\u201315. https:\/\/doi.org\/10.4103\/2319-4170.107154 (2013).","journal-title":"Biomed. J."},{"key":"86468_CR9","first-page":"159","volume":"99","author":"K Chomtho","year":"2016","unstructured":"Chomtho, K., Suteerojntrakool, O. & Chomtho, S. Effectiveness of medium chain triglyceride ketogenic diet in thai children with intractable epilepsy. J. Med. Assoc. Thai. 99, 159\u2013165 (2016).","journal-title":"J. Med. Assoc. Thai."},{"key":"86468_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trci.2017.11.002","volume":"4","author":"MK Taylor","year":"2018","unstructured":"Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M. & Swerdlow, R. H. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia Transl. Res. Clin. Interv. 4, 28\u201336 (2018).","journal-title":"Alzheimer's Dementia Transl. Res. Clin. Interv."},{"key":"86468_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin, K. et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 17, 84\u201393 (2018).","journal-title":"Lancet Neurol."},{"key":"86468_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/ajcn\/87.3.621","volume":"87","author":"M-P St-Onge","year":"2008","unstructured":"St-Onge, M.-P. & Bosarge, A. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am. J. Clin. Nutr. 87, 621\u2013626 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"86468_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jand.2014.10.022","volume":"115","author":"K Mumme","year":"2015","unstructured":"Mumme, K. & Stonehouse, W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J. Acad. Nutr. Diet. 115, 249\u2013263 (2015).","journal-title":"J. Acad. Nutr. Diet."},{"key":"86468_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/brain\/awv325","volume":"139","author":"P Chang","year":"2015","unstructured":"Chang, P. et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139, 431\u2013443. https:\/\/doi.org\/10.1093\/brain\/awv325 (2015).","journal-title":"Brain"},{"key":"86468_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2013.10.010","volume":"73","author":"W-C Huang","year":"2014","unstructured":"Huang, W.-C. et al. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid. J. Dermatol. Sci. 73, 232\u2013240 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"86468_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1074\/jbc.M111.294785","volume":"287","author":"RR Malapaka","year":"2012","unstructured":"Malapaka, R. R. et al. Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors. J. Biol. Chem. 287, 183\u2013195 (2012).","journal-title":"J. Biol. Chem."},{"key":"86468_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1210\/jc.2013-4275","volume":"99","author":"CP Hawkes","year":"2014","unstructured":"Hawkes, C. P. & Levine, M. A. Ketotic hypercalcemia: a case series and description of a novel entity. J. Clin. Endocrinol. Metab. 99, 1531\u20131536 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"86468_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eplepsyres.2017.07.014","volume":"136","author":"PJ Simm","year":"2017","unstructured":"Simm, P. J. et al. The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 136, 62\u201366. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.07.014 (2017).","journal-title":"Epilepsy Res."},{"key":"86468_CR19","doi-asserted-by":"publisher","first-page":"46457","DOI":"10.1038\/srep46457","volume":"7","author":"S Sekar","year":"2017","unstructured":"Sekar, S. et al. Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci. Rep. 7, 46457. https:\/\/doi.org\/10.1038\/srep46457 (2017).","journal-title":"Sci. Rep."},{"key":"86468_CR20","doi-asserted-by":"publisher","first-page":"e27739","DOI":"10.1371\/journal.pone.0027739","volume":"6","author":"E-J Park","year":"2011","unstructured":"Park, E.-J. et al. Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis. PLoS ONE 6, e27739 (2011).","journal-title":"PLoS ONE"},{"key":"86468_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.14348\/molcells.2014.0153","volume":"37","author":"H-J Kim","year":"2014","unstructured":"Kim, H.-J., Yoon, H.-J., Kim, S.-Y. & Yoon, Y.-R. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-\u03baB signaling and blocks cytoskeletal organization and survival in mature osteoclasts. Mol. Cells 37, 598 (2014).","journal-title":"Mol. Cells"},{"key":"86468_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"86468_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00223-018-0468-3","volume":"104","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Metformin alleviates the bone loss induced by ketogenic diet: an in vivo study in mice. Calcif. Tissue Int. 104, 59\u201369 (2019).","journal-title":"Calcif. Tissue Int."},{"key":"86468_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2019.03.024","volume":"164","author":"S Pal","year":"2019","unstructured":"Pal, S. et al. The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts. Biochem. Pharmacol. 164, 34\u201344. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.024 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"86468_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography. J. Bone Miner. Res. 25, 1468\u20131486. https:\/\/doi.org\/10.1002\/jbmr.141 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"86468_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1139\/o76-051","volume":"54","author":"M Tenniswood","year":"1976","unstructured":"Tenniswood, M., Bird, C. E. & Clark, A. F. Acid phosphatases: androgen dependent markers of rat prostate. Can. J. Biochem. 54, 350\u2013357. https:\/\/doi.org\/10.1139\/o76-051 (1976).","journal-title":"Can. J. Biochem."},{"key":"86468_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14740338.2019.1625887","volume":"18","author":"B Miziak","year":"2019","unstructured":"Miziak, B., Chro\u015bci\u0144ska-Krawczyk, M. & Czuczwar, S. J. An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs. Exp. Opin. Drug Saf. 18, 679\u2013689 (2019).","journal-title":"Exp. Opin. Drug Saf."},{"key":"86468_CR28","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/epi.13833","volume":"58","author":"A Khabbush","year":"2017","unstructured":"Khabbush, A. et al. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: a mechanistic insight into the medium-chain triglyceride ketogenic diet. Epilepsia 58, 1423\u20131429 (2017).","journal-title":"Epilepsia"},{"key":"86468_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2016.03.115","volume":"473","author":"M Yamasaki","year":"2016","unstructured":"Yamasaki, M., Hasegawa, S., Imai, M., Takahashi, N. & Fukui, T. High-fat diet-induced obesity stimulates ketone body utilization in osteoclasts of the mouse bone. Biochem. Biophys. Res. Commun. 473, 654\u2013661. https:\/\/doi.org\/10.1016\/j.bbrc.2016.03.115 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"86468_CR30","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.biomaterials.2007.03.003","volume":"28","author":"Y Zhao","year":"2007","unstructured":"Zhao, Y., Zou, B., Shi, Z., Wu, Q. & Chen, G.-Q.J.B. The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats. Biomaterials 28, 3063\u20133073 (2007).","journal-title":"Biomaterials"},{"key":"86468_CR31","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.1016\/j.biomaterials.2014.06.020","volume":"35","author":"Q Cao","year":"2014","unstructured":"Cao, Q. et al. The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity. Biomaterials 35, 8273\u20138283 (2014).","journal-title":"Biomaterials"},{"key":"86468_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fendo.2019.00880","volume":"10","author":"IA Heikura","year":"2020","unstructured":"Heikura, I. A. et al. A short-term ketogenic diet impairs markers of bone health in response to exercise. Front. Endocrinol. 10, 880 (2020).","journal-title":"Front. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86468-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86468-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:57:31Z","timestamp":1670047051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86468-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86468"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86468-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7003"}}